Mallinckrodt Pharmaceuticals Overview

  • Year Founded
  • 1866

Year Founded

  • Status
  • Private

  • Employees
  • 3,371

Employees

  • Latest Deal Type
  • Debt - Merger

  • Financing Rounds
  • 19

  • Investments
  • 18

Mallinckrodt Pharmaceuticals General Information

Description

Developer of specialty pharmaceutical products focused on improving outcomes for patients with severe and critical conditions. The company offers autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology, and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products, thereby enabling clients with precise drugs as per their health conditions.

Contact Information

Formerly Known As
G. Mallinckrodt & Co., Imcera Group Inc, Mallinckrodt Group Inc
Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Corporate Office
  • College Business and Technology Park
  • Cruiserath, Blanchardstown
  • Dublin 15
  • Ireland
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Commercial Products
Vertical(s)
Corporate Office
  • College Business and Technology Park
  • Cruiserath, Blanchardstown
  • Dublin 15
  • Ireland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mallinckrodt Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Mallinckrodt Pharmaceuticals‘s full profile, request access.

Request a free trial

Mallinckrodt Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of specialty pharmaceutical products focused on improving outcomes for patients with severe and critical condi
Other Pharmaceuticals and Biotechnology
Dublin, Ireland
3,371 As of 2025

Vienna, Austria
 

Amman, Jordan
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Mallinckrodt Pharmaceuticals Competitors (13)

One of Mallinckrodt Pharmaceuticals’s 13 competitors is Pfizer (Vienna), a Corporation company based in Vienna, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfizer (Vienna) Corporation Vienna, Austria
MS Pharma Private Equity-Backed Amman, Jordan
Genzyme Ireland Corporation Kilmeaden, Ireland
Novo Nordisk Corporation Bagsvaerd, Denmark
Verona Pharma Corporate Backed or Acquired London, United Kingdom
You’re viewing 5 of 13 competitors. Get the full list »

Mallinckrodt Pharmaceuticals Patents

Mallinckrodt Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210290537-A1 Liposomal elinafide formulations and uses thereof Inactive 08-Dec-2016
WO-2018106980-A1 Liposomal elinafide formulations and uses thereof Inactive 08-Dec-2016
US-20200079785-A1 Mitomycin c prodrug liposome formulations and uses thereof Inactive 08-Nov-2016
WO-2018089481-A1 Mitomycin c prodrug liposome formulations and uses thereof Inactive 08-Nov-2016
US-20200001109-A1 Methods for treating hyperbilirubinemia with stannsoporfin and phototherapy Inactive 12-May-2016 A61N5/0621
To view Mallinckrodt Pharmaceuticals’s complete patent history, request access »

Mallinckrodt Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mallinckrodt Pharmaceuticals Investments & Acquisitions (18)

Mallinckrodt Pharmaceuticals’s most recent deal was a Merger/Acquisition with Endo International for . The deal was made on 31-Jul-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Endo International 31-Jul-2025 Merger/Acquisition Pharmaceuticals
Endo (Pharmaceuticals) 13-Mar-2025 Merger/Acquisition Pharmaceuticals
Sucampo Pharmaceuticals 01-Feb-2018 Merger/Acquisition Pharmaceuticals
Ocera Therapeutics 01-Dec-2017 Merger/Acquisition Biotechnology
InfaCare Pharmaceutical 25-Sep-2017 Merger/Acquisition Other Pharmaceuticals and Biotechnology
You’re viewing 5 of 18 investments and acquisitions. Get the full list »

Mallinckrodt Pharmaceuticals Exits (4)

Mallinckrodt Pharmaceuticals’s most recent exit was on 01-Feb-2016 from The Medicines Company. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
The Medicines Company 01-Feb-2016 Completed
Therakos 25-Sep-2015 Completed
Gablofen 03-Oct-2012 Completed
Tensys Medical 27-Nov-2006 Later Stage VC Completed
  • 5 buyers
To view Mallinckrodt Pharmaceuticals’s complete exits history, request access »

Mallinckrodt Pharmaceuticals Affiliates

Subsidiaries (15)

Name Industry Location Year Founded
Sucampo International Holdings London, United Kingdom 2020
Therakos Europe Dublin, Ireland 2018
Mallinckrodt Finance Management Ireland Dublin, Ireland 2015
Mallinckrodt Pharma Ip Trading Unlimited Company Dublin, Ireland 2015
Keenova International Holdings Luxembourg, Luxembourg 2015
You’re viewing 5 of 15 affiliates. Get the full list.  »

Mallinckrodt Pharmaceuticals FAQs

  • When was Mallinckrodt Pharmaceuticals founded?

    Mallinckrodt Pharmaceuticals was founded in 1866.

  • Where is Mallinckrodt Pharmaceuticals headquartered?

    Mallinckrodt Pharmaceuticals is headquartered in Dublin, Ireland.

  • What is the size of Mallinckrodt Pharmaceuticals?

    Mallinckrodt Pharmaceuticals has 3,371 total employees.

  • What industry is Mallinckrodt Pharmaceuticals in?

    Mallinckrodt Pharmaceuticals’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Mallinckrodt Pharmaceuticals a private or public company?

    Mallinckrodt Pharmaceuticals is a Private company.

  • What is Mallinckrodt Pharmaceuticals’s current revenue?

    The current revenue for Mallinckrodt Pharmaceuticals is .

  • How much funding has Mallinckrodt Pharmaceuticals raised over time?

    Mallinckrodt Pharmaceuticals has raised $2.82B.

  • Who are Mallinckrodt Pharmaceuticals’s competitors?

    Pfizer (Vienna), MS Pharma, Genzyme Ireland, Novo Nordisk, and Verona Pharma are some of the 13 competitors of Mallinckrodt Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process